Clinical Trials Logo

Lung clinical trials

View clinical trials related to Lung.

Filter by:

NCT ID: NCT06115395 Recruiting - Lung Clinical Trials

Non-invasive Ventilation Assisted Fiber-optic Bronchoscopy

Start date: July 25, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is the evaluation of using bi-level positive airway pressure ventilation in candidates for fiber-optic bronchoscopy regarding benefits and drawbacks.

NCT ID: NCT05714033 Recruiting - Lung Clinical Trials

A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy During Robotic Bronchoscopy (VESPA vs. LADS Trial)

Start date: February 10, 2023
Phase: N/A
Study type: Interventional

To learn if LADS is better than VESPA at preventing atelectasis during a robotic bronchoscopy.

NCT ID: NCT05268263 Completed - Lung Clinical Trials

Feasibility of AI-based Classification of Normal, Wheeze and Crackle Sounds From Stethoscope in Clinical Settings

Start date: January 6, 2022
Phase: N/A
Study type: Interventional

Assessing the feasibility and testing the accuracy of the developed artificial intelligence algorithms for detection of wheezes and crackles in patients with lung pathologies in clinical settings on unseen local patient data acquired through three digital stethoscopes.

NCT ID: NCT05055739 Recruiting - Lung Transplant Clinical Trials

Comparative Study Between Sternal Closure With Sternalock® Blue Versus Steel Wire Submitted To Bilateral Anterior Transsternal Thoracotomy (Clamshell) For Bilateral Lung Transplant

LungTx-Lock
Start date: May 2, 2019
Phase: N/A
Study type: Interventional

This will be a prospective, randomized clinical trial, comparing the sternal alignment between the fixation with rigid plate X steel wires. Patients over 18 years of age, belonging to the lung transplant line in the State of São Paulo, who will undergo bilateral lung transplantation will be studied.

NCT ID: NCT05050370 Recruiting - Cancer Clinical Trials

A Brief SMART Exercise Instant Messaging Support Intervention - a Pilot Study

Start date: February 4, 2021
Phase: N/A
Study type: Interventional

Lung cancer is one of the most common cancer diseases, globally and locally. Several health benefits of increased physical activity (PA) have been reported for people with cancer. PA plays a critical role across the cancer trajectory, from prevention through to post-diagnosis and has been proposed as an alternative for improving physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality. Although there are a variety of exercise intervention programs for cancer patients, those programs were quite intensive, requiring individuals to commit extra time and effort. Feeling of overwhelmed appointments, lack of time, other barriers, including high cost and limited access to facilities are the most frequently reported barriers that prevent people from starting and maintaining exercise. Hence, the investigators propose to use a brief messaging lifestyle modification intervention program to incorporating simple and easy-to-do patient-centred home-based lifestyle-integrated exercise into daily activities of patients with lung cancer. The aims are to explore the feasibility of using instant messaging to enhance physical activity and improve their fatigue, emotion and quality of life, and obtain feedback from patients for intervention and study design improvement.

NCT ID: NCT04616820 Not yet recruiting - Cardiac Surgery Clinical Trials

Endocan Blood Level in Pulmonary Circulation

ENDOPULM
Start date: March 2021
Phase:
Study type: Observational

Endocan is a proteoglycan produced by the vascular endothelium. Animal studies suggested that the synthesis mainly happen in the pulmonary circulation, but this hypothesis has never been confirmed in humans.

NCT ID: NCT02849041 Active, not recruiting - Cancer Clinical Trials

Screening of Tobacco-induced Cancers by Low-dose CT-scanner and Identification of Circulating Tumor Cells

DETeCTOR
Start date: January 23, 2017
Phase: N/A
Study type: Interventional

Tobacco smoke is the most common source of exposure to carcinogens in humans. Indeed, the smoke contains about 1010 particles per ml and 4800 chemical compounds, at least 66 are carcinogenic. Tobacco smoke is the leading preventable cause of cancer in humans since it is responsible for lung cancer, upper aerodigestive tract (mouth, pharynx, larynx, esophagus), nasal cavity and sinuses, stomach, pancreas, liver, bladder, kidney, uterine cervix, and some myeloid leukemias. This study aims to evaluate the combined effect of the scanner and the search for circulating tumor cells (CTC) on screening for tobacco-related cancers, accompanying smokers to cessation and addressing the psychological impact this approach.

NCT ID: NCT02833246 Completed - Sarcoma Clinical Trials

Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

Start date: June 28, 2016
Phase: N/A
Study type: Interventional

This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.

NCT ID: NCT02535013 Completed - Ultrasonography Clinical Trials

Intraoperative Lung Ultrasound in Pediatric Patients

LUS
Start date: August 2015
Phase: N/A
Study type: Interventional

Investigators hypothesized that perioperative lung ultrasound would be beneficial in pediatric patients undergoing cardiac surgery compared to those who did not receive lung ultrasound.

NCT ID: NCT02201446 Recruiting - Inflammation Clinical Trials

The Role of Circulating Soluble CD74 in Acute Lung Injury

Start date: March 2014
Phase: N/A
Study type: Observational

Efforts to identify circulating factors that predict severity of acute lung injury/acute respiratory distress syndrome(ALI/ARDS) patients is unrevealing. The primary purpose of this study is to verify our hypothesis that soluble CD74 might be a potential novel ALI/ARDS biomarker.